Literature DB >> 25596142

Relative flow reserve derived from quantitative perfusion imaging may not outperform stress myocardial blood flow for identification of hemodynamically significant coronary artery disease.

Wijnand J Stuijfzand1, Valtteri Uusitalo1, Tanja Kero1, Ibrahim Danad1, Mischa T Rijnierse1, Antti Saraste1, Pieter G Raijmakers1, Adriaan A Lammertsma1, Hans J Harms1, Martijn W Heymans1, Marc C Huisman1, Koen M Marques1, Sami A Kajander1, Mikko Pietilä1, Jens Sörensen1, Niels van Royen1, Juhani Knuuti1, Paul Knaapen2.   

Abstract

BACKGROUND: Quantitative myocardial perfusion imaging is increasingly used for the diagnosis of coronary artery disease. Quantitative perfusion imaging allows to noninvasively calculate fractional flow reserve (FFR). This so-called relative flow reserve (RFR) is defined as the ratio of hyperemic myocardial blood flow (MBF) in a stenotic area to hyperemic MBF in a normal perfused area. The aim of this study was to assess the value of RFR in the detection of significant coronary artery disease. METHODS AND
RESULTS: From a clinical population of patients with suspected coronary artery disease who underwent oxygen-15-labeled water cardiac positron emission tomography and invasive coronary angiography, 92 patients with single- or 2-vessel disease were included. Intermediate lesions (diameter stenosis, 30%-90%; n=75) were interrogated by FFR. Thirty-eight (41%) vessels were deemed hemodynamically significant (>90% stenosis or FFR≤0.80). Hyperemic MBF, coronary flow reserve, and RFR were lower for vessels with a hemodynamically significant lesion (2.01±0.78 versus 2.90±1.16 mL·min(-1)·g(-1); P<0.001, 2.27±1.03 versus 3.10±1.29; P<0.001, and 0.67±0.23 versus 0.93±0.15; P<0.001, respectively). The correlation between RFR and FFR was moderate (r=0.54; P<0.01). Receiver operator characteristic curve analysis showed an area under the curve of 0.82 for RFR, which was not significantly higher compared with that for hyperemic MBF and coronary flow reserve (0.76; P=0.32 and 0.72; P=0.08, respectively).
CONCLUSIONS: Noninvasive estimation of FFR by quantitative perfusion positron emission tomography by calculating RFR is feasible, yet only a trend toward a slight improvement of diagnostic accuracy compared with hyperemic MBF assessment was determined.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  coronary angiography; coronary artery disease; fractional flow reserve, myocardial; positron-emission tomography

Mesh:

Substances:

Year:  2015        PMID: 25596142     DOI: 10.1161/CIRCIMAGING.114.002400

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  24 in total

1.  Feasibility of dynamic stress 201Tl/rest 99mTc-tetrofosmin single photon emission computed tomography for quantification of myocardial perfusion reserve in patients with stable coronary artery disease.

Authors:  Sangwon Han; Young-Hak Kim; Jung-Min Ahn; Soo-Jin Kang; Jungsu S Oh; Eonwoo Shin; Changhwan Sung; Sun Young Chae; Seung-Jung Park; Gillan Grimberg; Gil Kovalski; Dae Hyuk Moon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-06-02       Impact factor: 9.236

2.  Hybrid anatomo-functional imaging of coronary artery disease: Beneficial irrespective of its core components.

Authors:  Francesco Nudi; Giuseppe Biondi-Zoccai; Andrea Romagnoli; Orazio Schillaci; Alessandro Nudi; Francesco Versaci
Journal:  J Nucl Cardiol       Date:  2018-12-18       Impact factor: 5.952

Review 3.  Quantification of PET Myocardial Blood Flow.

Authors:  Matthieu Pelletier-Galarneau; Patrick Martineau; Georges El Fakhri
Journal:  Curr Cardiol Rep       Date:  2019-02-28       Impact factor: 2.931

4.  15-O-water myocardial flow reserve PET and CT angiography by full hybrid PET/CT as a potential alternative to invasive angiography.

Authors:  Anders Thomassen; Poul-Erik Braad; Kasper T Pedersen; Henrik Petersen; Allan Johansen; Axel C P Diederichsen; Hans Mickley; Lisette O Jensen; Juhani Knuuti; Oke Gerke; Poul F Høilund-Carlsen
Journal:  Int J Cardiovasc Imaging       Date:  2018-07-31       Impact factor: 2.357

5.  Rationale and design of the quantification of myocardial blood flow using dynamic PET/CTA-fused imagery (DEMYSTIFY) to determine physiological significance of specific coronary lesions.

Authors:  Ahmed AlBadri; Marina Piccinelli; Sang-Geon Cho; Joo Myung Lee; Wissam Jaber; Carlo N De Cecco; Habib Samady; Bon-Kwon Koo; Hee-Seung Bom; Ernest V Garcia
Journal:  J Nucl Cardiol       Date:  2020-02-05       Impact factor: 5.952

Review 6.  Static and dynamic assessment of myocardial perfusion by computed tomography.

Authors:  Ibrahim Danad; Jackie Szymonifka; Joshua Schulman-Marcus; James K Min
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2016-03-24       Impact factor: 6.875

7.  Corrected coronary opacification decrease from coronary computed tomography angiography: Validation with quantitative 13N-ammonia positron emission tomography.

Authors:  Dominik C Benz; Christoph Gräni; Paola Ferro; Luis Neumeier; Michael Messerli; Mathias Possner; Olivier F Clerc; Catherine Gebhard; Oliver Gaemperli; Aju P Pazhenkottil; Philipp A Kaufmann; Ronny R Buechel
Journal:  J Nucl Cardiol       Date:  2017-07-06       Impact factor: 5.952

Review 8.  PET measurements of myocardial blood flow post myocardial infarction: Relationship to invasive and cardiac magnetic resonance studies and potential clinical applications.

Authors:  Henry Gewirtz
Journal:  J Nucl Cardiol       Date:  2017-06-02       Impact factor: 5.952

Review 9.  Coronary circulation: Pressure/flow parameters for assessment of ischemic heart disease.

Authors:  Henry Gewirtz
Journal:  J Nucl Cardiol       Date:  2018-04-10       Impact factor: 5.952

10.  Vessel-specific quantification of absolute myocardial blood flow, myocardial flow reserve and relative flow reserve by means of fused dynamic 13NH3 PET and CCTA: Ranges in a low-risk population and abnormality criteria.

Authors:  Marina Piccinelli; Sang-Geon Cho; Ernest V Garcia; Erick Alexanderson; Joo Myung Lee; C David Cooke; Nikhil Goyal; Mauricio Santos Sanchez; Russel D Folks; Zhengjia Chen; John Votaw; Bon-Kwon Koo; Hee-Seung Bom
Journal:  J Nucl Cardiol       Date:  2018-10-29       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.